The latest Investing Matters Podcast episode featuring financial educator and author Jared Dillian has been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksInspiration Hlt Regulatory News (IHC)

Share Price Information for Inspiration Hlt (IHC)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 16.75
Bid: 16.50
Ask: 17.00
Change: 0.00 (0.00%)
Spread: 0.50 (3.03%)
Open: 16.75
High: 16.75
Low: 16.20
Prev. Close: 16.75
IHC Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Appointment of Dr. Peter Reynolds

23 Sep 2020 07:00

RNS Number : 7704Z
Inspiration Healthcare Group PLC
23 September 2020
 

Inspiration Healthcare Group plc

 ("Inspiration Healthcare", the "Company" or the "Group")

 

Appointment of Dr. Peter Reynolds

 

Inspiration Healthcare Group plc (AIM: IHC), the global medical technology company, is pleased to announce that it has appointed Dr. Peter Reynolds as the Group's Vice President for Clinical Innovation and Compliance. Peter is a Consultant Neonatologist and Paediatrician based at St. Peter's Hospital, Chertsey, Surrey and has a strong track record in research, quality improvement and teaching. He holds an MB.BS medical degree, a MSc (University of London) in Clinical Paediatrics, and a PhD (Imperial College London) in Immunology. He has also achieved the MRCPCH, MRCGP and DRCOG Royal Colleges exams. 

As a Consultant Neonatologist he specialises in the care of premature and sick babies and the outpatient management of babies and infants. Peter is also the clinical Speciality Neonatal Lead, Neonatal Research Lead, Joint South East Neonatal Network Clinical Lead, and Honorary Senior Lecturer at Royal Holloway University of London. In 2018, he won the "Who Cares Wins" award for Best Neonatal Specialist in the UK.

 

At Inspiration Healthcare, as a non-Board member he will work closely with the senior management team to drive forward the Company's clinical research, compliance (Quality Assurance and Regulatory Affairs), R&D and Product management and will join the Company on the 12th October 2020.

 

Dr. Reynolds said 'I am truly delighted to join this growing and ambitious company which is focussed on developing important products to help improve the outcomes of sick and premature babies. I will bring my extensive clinical experience and knowledge of neonatology to help lead clinical product development and future innovations for the Group. This is an exciting challenge for me personally and I look forward to making a real contribution to the success of this dynamic company.'

 

Neil Campbell, Chief Executive Officer, commented, "We have known Peter for many years and welcome his expertise and experience which will be invaluable as the Company continues to grow and upskill its clinical expertise. He is an extremely well known and recognised figure in our specialist industry having written a wide range of publications and through his teaching and lecturing in the UK as well internationally and we are looking forward to working with him."

 

 

Enquiries:

 

Inspiration Healthcare Group plc

Neil Campbell, Chief Executive Officer

Jon Ballard, Chief Financial Officer

Tel: 01455 840555

 

Nominated Adviser & Broker

Cenkos Securities plc

Mark Connelly

Stephen Keys

Cameron MacRitchie

Tel: 0207 397 8900

 

Cadogan PR

Alex Walters

alex.walters@cadoganpr.com

Tel: 07771 713608

 

 

About Inspiration Healthcare Group

 

Inspiration Healthcare (AIM: IHC) is a global provider of medical technology for use in neonatal intensive care & operating theatres. The Company provides high quality innovative products to patients around the world which help to improve patient outcomes and it actively invests in innovative product opportunities and disruptive technologies.

The Company has key own brand products that can be used within the first days of life to help premature and sick babies; helping resuscitation and stabilisation in the first moments of life through to preventing brain damage and both invasive and non-invasive respiratory support in terms of capital equipment and disposable medical devices. Additionally, the Company has its own range of products for maintaining normothermia pre, during and post-surgery.

Since September 2019, the Company has acquired Vio Holdings a designer, manufacturer and supplier of single use respiratory products and sterile medical consumables and S.L.E., a leading designer, manufacturer and global provider of neonatal ventilation products. The Group generates approximately 60% of its revenues from export markets and around two-thirds of its revenues come from its own-branded products.

With product availability actively promoted to over 75 countries through a distribution network, Inspiration Healthcare's success has been built on continuous innovation, excellent customer service and an inherent commitment to improving patient outcomes, working in close collaboration with key opinion leaders across the globe.

In the UK and Ireland the Group has direct sales teams selling Group Branded and complementary products from third parties, with an additional range of home healthcare products. This is supported by Technical Support for planned preventative maintenance and emergency assistance.

The Group operates from various sites in the UK for R&D, Marketing and operations with manufacturing based in Croydon (south London) and Hailsham (East Sussex). The Group's Head Office is located in Crawley, a short distance from London's Gatwick Airport. Further information on Inspiration Healthcare can be found at www.inspiration-healthcare.com

This information is provided by Reach, the non-regulatory press release distribution service of RNS, part of the London Stock Exchange. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Private Policy.
 
END
 
 
NRAKKBBQQBKDACB
Date   Source Headline
1st May 20247:00 amRNSTrading update
9th Apr 20247:00 amRNSGrant of Options under Sharesave Scheme
1st Feb 202411:33 amRNSGrant of Covenant Waiver
31st Jan 20247:00 amRNSTrading update
18th Jan 20247:00 amRNSMDSAP certification
15th Jan 20243:04 pmRNSDirector/PDMR Shareholding
4th Jan 20247:00 amRNSStrategic acquisition of Airon Corporation
7th Dec 20237:00 amRNSDirectorate Change
2nd Nov 20237:00 amRNSLaunch of SLE1500 Non-Invasive Ventilator
31st Oct 202310:18 amRNSHolding(s) in Company
17th Oct 20237:00 amRNSDirector/PDMR Shareholding
16th Oct 20237:00 amRNSDirector/PDMR Shareholding
16th Oct 20237:00 amRNSDirector/PDMR Shareholding
16th Oct 20237:00 amRNSDirector/PDMR Shareholding
16th Oct 20237:00 amRNSDirector/PDMR Shareholding
12th Oct 20237:00 amRNSShareSoc investor presentation
3rd Oct 20237:00 amRNSHalf-year Report
22nd Sep 20237:00 amRNSInvestor results presentation
31st Aug 20237:00 amRNSTrading update
12th Jul 202310:45 amRNSHolding(s) in Company
10th Jul 20237:00 amRNSChange of Registered Office
27th Jun 202312:20 pmRNSResult of AGM
27th Jun 20237:00 amRNSAGM Statement
22nd Jun 20237:00 amRNSAppointment of Non-Executive Director
13th Jun 20232:00 pmRNSInvestor presentation
12th Jun 20237:00 amRNSCFO appointment
9th Jun 20237:00 amRNSGrant of Options
5th Jun 20235:13 pmRNSHolding(s) in Company
5th Jun 20237:00 amRNSHolding(s) in Company
2nd Jun 20237:00 amRNSNotice of AGM and posting of Annual Report
1st Jun 20233:27 pmRNSAIM Rule 17 Schedule Two (g) Update
1st Jun 20238:55 amRNSHolding(s) in Company
24th May 20237:00 amRNSAppointment of Nominated Adviser and Broker
17th May 20237:00 amRNSMello investor conference
4th May 20237:00 amRNSInvestor Day
3rd May 20237:00 amRNSFinal Results
6th Apr 20235:53 pmRNSGrant of Options
3rd Apr 20235:53 pmRNSGrant of Options
31st Mar 20236:27 pmRNSExercise of Options & Issue of Equity
23rd Mar 20237:00 amRNSLaunch of range extension of neonatal ventilators
1st Mar 20237:00 amRNSChange of Website
17th Feb 20232:05 pmRNSTR1 Notification
16th Feb 20237:00 amRNSTrading Update
9th Dec 20222:27 pmRNSTR1 Notification
8th Dec 20221:10 pmRNSTR1 Notification
5th Dec 20227:00 amRNSBoard Changes
30th Nov 202210:28 amRNSDirector / PDMR Dealing
28th Nov 20222:05 pmRNSSecond Price Monitoring Extn
28th Nov 20222:00 pmRNSPrice Monitoring Extension
28th Nov 20229:05 amRNSSecond Price Monitoring Extn

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.